Lumida
/EDIT
⌘K
Editas Medicine Inc

Editas Medicine Inc

EDIT
$2.98USD+3.47%+0.10 today

MARKET CAP

457.3M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$2
$5

AI Summary

Stalk
Sell NowHigh

EDIT remains in a Stage 4 decline with a clear sequence of lower highs and lower lows under declining EMAs. The medium-term bias is bearish, reinforced by the active Bearish Pivot Point pattern and volume skewed to down moves. Short-term price is trading below the 9/20 EMA with follow-through, supporting immediate sell-side participation in the breakdown below EMAs and recent range lows.

  • 40-patient Renicel Ruby trial enrollment supports mid-2024 clinical data release.
  • RMAT designation from FDA expedites BLA path, boosting approval prospects.
  • Earnings yield -3.5% and negative profitability factors signal investor caution.
Full analysis →
Insider Trades37 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 3, 2026SellEDITAmy ParisonSVP, Chief Financial Officer464$2.70$457.3M-34.32%+79.52%$1.3K-3.01%Trim
Jun 3, 2026SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER731$2.70$457.3M-34.32%+79.52%$2.0K-1.07%Trim
Jun 3, 2026SellEDITGilmore Neil O'NeillCEO15,380$2.70$457.3M-34.32%+79.52%$41.5K-5.83%Trim
Mar 3, 2026SellEDITAmy ParisonSVP, Chief Financial Officer474$2.02$457.3M-34.32%+79.52%$957.48-2.98%Trim
Mar 3, 2026SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER749$2.02$457.3M-34.32%+79.52%$1.5K-1.09%Trim
Mar 3, 2026SellEDITGilmore Neil O'NeillCEO5,394$2.02$457.3M-34.32%+79.52%$10.9K-2.00%Trim
Dec 3, 2025SellEDITAmy ParisonSVP, Chief Financial Officer461$2.15$457.3M-34.32%+79.52%$992.579-2.82%Trim
Dec 3, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER713$2.15$457.3M-34.32%+79.52%$1.5K-1.03%Trim
Dec 3, 2025SellEDITGilmore Neil O'NeillCEO5,603$2.15$457.3M-34.32%+79.52%$12.1K-2.04%Trim
Sep 3, 2025SellEDITAmy ParisonSVP, Chief Financial Officer458$2.60$457.3M-34.32%+79.52%$1.2K-2.72%Trim
Sep 3, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER710$2.60$457.3M-34.32%+79.52%$1.8K-1.01%Trim
Sep 3, 2025SellEDITGilmore Neil O'NeillCEO5,592$2.60$457.3M-34.32%+79.52%$14.5K-2.00%Trim
Aug 7, 2025SellEDITAmy ParisonSVP, Chief Financial Officer679$2.58$457.3M-34.32%+79.52%$1.8K-3.88%Trim
Jul 31, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER5,121$2.49$457.3M-34.32%+79.52%$12.8K-7.37%Trim
Jun 3, 2025SellEDITAmy ParisonSVP, Chief Financial Officer446$1.72$457.3M-34.32%+79.52%$768.904-2.48%Trim
Jun 3, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER726$1.72$457.3M-34.32%+79.52%$1.3K-1.03%Trim
Jun 3, 2025SellEDITGilmore Neil O'NeillCEO15,192$1.72$457.3M-34.32%+79.52%$26.2K-5.14%Trim
Mar 4, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER2,891$1.71$457.3M-34.32%+79.52%$4.9K-3.95%Trim
Mar 4, 2025SellEDITErick LuceraEVP, CHIEF FINANCIAL OFFICER4,109$1.71$457.3M-34.32%+79.52%$7.0K-3.52%Trim
Mar 4, 2025SellEDITGilmore Neil O'NeillCEO16,632$1.71$457.3M-34.32%+79.52%$28.5K-5.33%Trim
Dec 3, 2024SellEDITBaisong MeiEVP, CHIEF MEDICAL OFFICER541$2.08$457.3M-34.32%+79.52%$1.1K-0.40%Trim
Dec 3, 2024SellEDITGilmore Neil O'NeillCEO1,618$2.08$457.3M-34.32%+79.52%$3.4K-0.52%Trim
Sep 4, 2024SellEDITBaisong MeiEVP, CHIEF MEDICAL OFFICER518$3.42$457.3M-34.32%+79.52%$1.8K-0.39%Trim
Sep 4, 2024SellEDITGilmore Neil O'NeillCEO1,555$3.42$457.3M-34.32%+79.52%$5.3K-0.49%Trim
Jul 25, 2024SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER11,886$5.42$457.3M-34.32%+79.52%$64.4K-13.98%Trim
Jul 19, 2024SellEDITBaisong MeiEVP, CHIEF MEDICAL OFFICER6,619$5.21$457.3M-34.32%+79.52%$34.5K-4.69%Trim
Jun 4, 2024SellEDITBaisong MeiEVP, CHIEF MEDICAL OFFICER511$5.50$457.3M-34.32%+79.52%$2.8K-0.36%Trim
Jun 4, 2024SellEDITGilmore Neil O'NeillCEO12,191$5.50$457.3M-34.32%+79.52%$67.0K-3.72%Trim
May 20, 2024SellEDITErick LuceraEVP, CHIEF FINANCIAL OFFICER22,337$5.61$457.3M-34.32%+79.52%$125.4K-16.05%Trim
Mar 5, 2024SellEDITGilmore Neil O'NeillCEO77,824$9.42$457.3M-34.32%+79.52%$732.9K-9.76%Trim
Mar 4, 2024SellEDITBaisong MeiSVP, CHIEF MEDICAL OFFICER20,327$9.42$457.3M-34.32%+79.52%$191.4K-6.46%Trim
Dec 5, 2023SellEDITBruce EatonEVP, CBO AND CTO103$10.90$457.3M-34.32%+79.52%$1.1K-0.14%Trim
Nov 14, 2023SellEDITBruce EatonEVP, CBO AND CTO695$8.21$457.3M-34.32%+79.52%$5.7K-0.92%Trim
Nov 7, 2023SellEDITBruce EatonEVP, CBO AND CTO139$8.40$457.3M-34.32%+79.52%$1.2K-0.18%Trim
Sep 6, 2023SellEDITBruce EatonEVP, CBO AND CTO103$8.82$457.3M-34.32%+79.52%$908.46-0.14%Trim
Aug 11, 2023SellEDITBruce EatonEVP, CBO AND CTO702$8.59$457.3M-34.32%+79.52%$6.0K-0.92%Trim
Aug 8, 2023SellEDITBruce EatonEVP, CBO AND CTO141$8.39$457.3M-34.32%+79.52%$1.2K-0.18%Trim